Recipient characteristics | Anti-HCV NAT positive organs (N = 22) | Anti-HCV NAT negative organs (N = 11) |
---|---|---|
Age (years) | 47.5 (42.3–62.0) | 56 (47–65.0) |
Male gender (%) | 13 (59.1) | 6 (54.5) |
Etiology of transplant | ||
A. Kidney (%) | ||
Diabetes | 4 (18.2) | 1 (9.1) |
Hypertension | 1 (4.5) | 4 (36.4) |
PCKD | 3 (13.6) | 1 (9.1) |
Nephrotic syndrome | 1 (4.5) | 1 (9.1) |
GN | 2 (9.1) | 0 (0) |
IgA nephropathy | 2 (9.1) | 0 (0) |
Light chain deposition disease | 1 (4.5) | 0 (0) |
Vasculitis | 0 (0) | 2 (18.2) |
Alport syndrome | 1 (4.5) | 0 (0) |
Reflux nephropathy | 1 (4.5) | 0 (0) |
ATN | 1 (4.5) | 0 (0) |
NYD | 1 (4.5) | 0 (0) |
B. Liver (%) | ||
ASH | 1 (4.5) | 2 (18.2) |
HCV | 1 (4.5) | 0 (0) |
Hepatocellular carcinoma | 2 (9.1) | 0 (0) |
C. Heart (%) | ||
Ischemic cardiomyopathy | 1 (4.5) | 0 (0) |
CMV (D+/R−) (%) Mismatch | 4 (18.2) | 3 (27.3) |